William H. Aaronson

Davis Polk is advising Novo Nordisk on its $145 million acquisition of the U.S. and Canadian rights to Macrilen from Strongbridge Biopharma Plc. Novo Nordisk will also acquire newly issued…

Davis Polk advised FMC Corporation in connection with the separation of its lithium division into a new publicly traded company, to be called Livent Corporation, and advised Livent in…

Davis Polk is advising Millicom on its acquisition of a controlling 80% stake in Cable Onda, the largest cable and fixed telecommunications services provider in Panama, at an enterprise…

Davis Polk is advising SUEZ S.A. on its $601 million sale of 20% of SUEZ Water Resources Inc. to PGGM. The transaction is expected to be completed by the first half of 2019, subject to…

Davis Polk is advising Comcast Corporation on its superior proposal to acquire the businesses that Twenty-First Century Fox, Inc. has agreed to sell to The Walt Disney Company for $35.00…

Davis Polk advised Comodo Group on the acquisition of a majority stake in its certificate authority business by Francisco Partners. Financial terms of the transaction were not disclosed…

Davis Polk is advising Advanced Accelerator Applications S.A. on its $3.9 billion acquisition by Novartis. Entry into the definitive agreement has been approved by the board of…

Davis Polk is advising Mitsubishi Tanabe Pharma Corporation on its approximately $1.1 billion acquisition of NeuroDerm Ltd. The transaction, which is expected to close in the fourth quarter…

Davis Polk is advising Comcast Corporation in connection with Comcast’s acquisition of majority ownership of Craftsy, a leader in the lifestyle learning entertainment space. Financial terms…

Davis Polk is advising the special committee of the board of directors of Ormat Technologies, Inc. in connection with the acquisition of an approximately $627 million ownership stake…